£104.99

De Gruyter PIPAC: Pressurized Intraperitoneal Aerosol Chemotherapy - Cancer Under Pressure (Phenomenology & Mind): 17

Price data last checked 47 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£105 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 44 days • 44 data points (No recent data available)

Historical
Generating forecast...
£160.12 £99.48 £112.71 £125.94 £139.17 £152.40 £165.63 09 March 2026 19 March 2026 30 March 2026 10 April 2026 21 April 2026

Price Distribution

Price distribution over 44 days • 2 price levels

Days at Price
Current Price
7 days · current 37 days 0 9 19 28 37 £105 £160 Days at Price

Price Analysis

Most common price: £160 (37 days, 84.1%)

Price range: £105 - £160

Price levels: 2 different prices over 44 days

Description

Peritoneal dissemination is a common route of cancer metastasis. The benefit of administering chemotherapy directly into the peritoneal cavity is supported by preclinical and pharmacokinetic data. In comparison to intravenous (IV) treatment, intraperitoneal (IP) administration results in a several-fold increase in drug concentration within the abdominal cavity. There is now growing evidence from clinical studies showing a survival advantage for IP chemotherapy in various tumor typies, including ovarian, gastric and colorectal cancer. However, while the use of IP chemotherapy is slowly gaining acceptance, it is not universal, largely due to the greater toxicity associated with this approach. Moreover, efficacy of IP chemotherapy is limited by poor distribution within the abdominal cavity and by poor tissue penetration. A new way of IP chemotherapy is the application of cytotoxics in form of a pressurized aerosol into the abdominal of thoracic cavity. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is applied through laparoscopic access using two balloon trocars in an operating room equipped with laminar air-flow. In a first step,a normothermic capnoperitoneum is established with a pressure of 12 mmHg. A cytotoxic solution (about 10% of a normal systemic dose) is nebulized with a micropump into the abdominal cavity, and maintained for 30 min. The aerosol is then removed through a closed suction system. Applying an aerosol in the peritoneal cavity allows a homogeneous distribution of the chemotherapeutic agent within the abdomen. Furthermore, an artificial pressure gradient is generated that overcomes tumoral interstitial fluid pressure, an obstacle in cancer therapy. This results in a higher local drug concentration compared to conventional IP or IV chemotherapy. At the same time the plasma concentration of the chemotherapeutic agent remains low. In first clinical studies with limited number of patients in ovarian, gastric and colorectal cancer, as well as peritoneal mesothelioma, PIPAC has obtained encouraging tumor response rates and survival, with a low-side effects profile. Larger clinical trials are currently ongoing to examine if these data can be reproduced and extrapolated to other situations.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
15 September 2014
Listed Since
19 November 2013

Barcode

No barcode data available

Similar Products You Might Like

Peritoneal Carcinomatosis: Drugs and Diseases: 81 (Cancer Treatment and Research, 81)
95% match

Peritoneal Carcinomatosis: Drugs and Diseases: 81 (Cancer Treatment and Research, 81)

Springer

£149.20 10 Mar 2026
Treatment of Peritoneal Surface Malignancies, An Issue of Surgical Oncology Clinics (Volume 21-4) (The Clinics: Surgery, Volume 21-4)
95% match

Treatment of Peritoneal Surface Malignancies, An Issue of Surgical Oncology Clinics (Volume 21-4) (The Clinics: Surgery, Volume 21-4)

Saunders

£52.79 04 Mar 2026
Peritoneal Carcinomatosis: A Multidisciplinary Approach: 134 (Cancer Treatment and Research, 134)
95% match

Peritoneal Carcinomatosis: A Multidisciplinary Approach: 134 (Cancer Treatment and Research, 134)

Springer

£103.00 12 Dec 2025
Peritoneal Tumors and Metastases: Surgical, intraperitoneal and systemic therapy
95% match

Peritoneal Tumors and Metastases: Surgical, intraperitoneal and systemic therapy

Springer

£113.97 09 Mar 2026
Peritoneal Carcinomatosis from Ovarian Cancer
94% match

Peritoneal Carcinomatosis from Ovarian Cancer

£109.07 14 Jan 2026
Intraperitoneal Therapy for Ovarian Cancer
94% match

Intraperitoneal Therapy for Ovarian Cancer

Springer

£106.59 15 Jan 2026
Peritoneal Carcinomatosis: Principles of Management: 82 (Cancer Treatment and Research, 82)
94% match

Peritoneal Carcinomatosis: Principles of Management: 82 (Cancer Treatment and Research, 82)

Springer

£242.71 23 Jan 2026
Peritoneal Carcinomatosis: Principles of Management: 82 (Cancer Treatment and Research, 82)
94% match

Peritoneal Carcinomatosis: Principles of Management: 82 (Cancer Treatment and Research, 82)

Springer

£201.01 23 Jan 2026
Intraperitoneal Cancer Therapy (Current Clinical Oncology)
94% match

Intraperitoneal Cancer Therapy (Current Clinical Oncology)

Humana

£38.89 09 Jan 2026
Treatment of Peritoneal Surface Malignancies: State of the Art and Perspectives (Updates in Surgery)
94% match

Treatment of Peritoneal Surface Malignancies: State of the Art and Perspectives (Updates in Surgery)

Springer

£83.75 10 Apr 2026
Intraperitoneal Cancer Therapy (Current Clinical Oncology)
94% match

Intraperitoneal Cancer Therapy (Current Clinical Oncology)

Humana

£79.93 06 Mar 2026
Pathology of Peritoneal Metastases: The Unchartered Fields
94% match

Pathology of Peritoneal Metastases: The Unchartered Fields

Springer

£88.34 05 Feb 2026
Cellular and Molecular Biology of Metals
94% match

Cellular and Molecular Biology of Metals

CRC Press

£150.18 10 Feb 2026
Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond
93% match

Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond

Springer

£81.28 25 Jan 2026
Targeted Therapies in Oncology
93% match

Targeted Therapies in Oncology

CRC Press

£56.99 20 Feb 2026
Prognostic and Therapeutic Applications of RKIP in Cancer
93% match

Prognostic and Therapeutic Applications of RKIP in Cancer

Academic Press

£96.59 09 Mar 2026
A Practical Guide to Peritoneal Malignancy: The PMI Manual
93% match

A Practical Guide to Peritoneal Malignancy: The PMI Manual

CRC Press

£165.81 27 Jan 2026
Isolation and Molecular Characterization of Circulating Tumor Cells: 994 (Advances in Experimental Medicine and Biology, 994)
93% match

Isolation and Molecular Characterization of Circulating Tumor Cells: 994 (Advances in Experimental Medicine and Biology, 994)

Springer

£128.11 19 Apr 2026
Contemporary Management of Metastatic Colorectal Cancer: A Precision Medicine Approach
93% match

Contemporary Management of Metastatic Colorectal Cancer: A Precision Medicine Approach

Academic Press

£108.96 26 Mar 2026
A Practical Guide to Peritoneal Malignancy: The PMI Manual
93% match

A Practical Guide to Peritoneal Malignancy: The PMI Manual

CRC Press

£69.56 01 Feb 2026
Hsp90 in Cancer: Beyond the Usual Suspects (Volume 129) (Advances in Cancer Research, Volume 129)
93% match

Hsp90 in Cancer: Beyond the Usual Suspects (Volume 129) (Advances in Cancer Research, Volume 129)

Academic Press

£110.59 10 Mar 2026
Treatment of Peritoneal Metastasis, An Issue of Surgical Oncology Clinics of North America (Volume 27-3) (The Clinics: Surgery, Volume 27-3)
93% match

Treatment of Peritoneal Metastasis, An Issue of Surgical Oncology Clinics of North America (Volume 27-3) (The Clinics: Surgery, Volume 27-3)

Elsevier

£68.52 28 Feb 2026
Metastasis Research Protocols: 1070 (Methods in Molecular Biology, 1070)
93% match

Metastasis Research Protocols: 1070 (Methods in Molecular Biology, 1070)

Humana

£74.07 07 Mar 2026
New Concepts in Diagnosis and Therapy of Pancreatic Adenocarcinoma (Medical Radiology)
93% match

New Concepts in Diagnosis and Therapy of Pancreatic Adenocarcinoma (Medical Radiology)

Springer

£84.55 09 Jan 2026